

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to cadmium ion (GO:0071276) | 8.89574712 |
| 2 | membrane raft organization (GO:0031579) | 5.90764202 |
| 3 | regulation of metalloenzyme activity (GO:0048552) | 5.46456444 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.35850312 |
| 5 | * response to zinc ion (GO:0010043) | 4.33320081 |
| 6 | barbed-end actin filament capping (GO:0051016) | 4.27155305 |
| 7 | protein heterotetramerization (GO:0051290) | 4.24281408 |
| 8 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 4.13410727 |
| 9 | fibrinolysis (GO:0042730) | 4.10227308 |
| 10 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.93823049 |
| 11 | response to cadmium ion (GO:0046686) | 3.91517321 |
| 12 | apoptotic cell clearance (GO:0043277) | 3.90238606 |
| 13 | cellular copper ion homeostasis (GO:0006878) | 3.88974664 |
| 14 | cell adhesion mediated by integrin (GO:0033627) | 3.82541248 |
| 15 | proteasome assembly (GO:0043248) | 3.71222737 |
| 16 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.66632210 |
| 17 | eosinophil chemotaxis (GO:0048245) | 3.55091926 |
| 18 | skin morphogenesis (GO:0043589) | 3.53694505 |
| 19 | endodermal cell differentiation (GO:0035987) | 3.47347694 |
| 20 | cellular response to arsenic-containing substance (GO:0071243) | 3.34785658 |
| 21 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.34573780 |
| 22 | pyrimidine-containing compound salvage (GO:0008655) | 3.32890967 |
| 23 | pyrimidine nucleoside salvage (GO:0043097) | 3.32890967 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 3.28821813 |
| 25 | membrane budding (GO:0006900) | 3.28421416 |
| 26 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.28002068 |
| 27 | copper ion homeostasis (GO:0055070) | 3.24449800 |
| 28 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.23145072 |
| 29 | protein retention in ER lumen (GO:0006621) | 3.19903470 |
| 30 | eosinophil migration (GO:0072677) | 3.09509874 |
| 31 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.07265069 |
| 32 | negative regulation of monooxygenase activity (GO:0032769) | 3.04132638 |
| 33 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.02346830 |
| 34 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.02142050 |
| 35 | cell migration involved in heart development (GO:0060973) | 3.01948037 |
| 36 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.97817991 |
| 37 | peptidyl-proline hydroxylation (GO:0019511) | 2.94755789 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.94386451 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 2.94386451 |
| 40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.94197324 |
| 41 | protein hydroxylation (GO:0018126) | 2.92982685 |
| 42 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.90261965 |
| 43 | negative regulation of coagulation (GO:0050819) | 2.89106778 |
| 44 | regulation of plasminogen activation (GO:0010755) | 2.86818853 |
| 45 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.84022444 |
| 46 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.80045160 |
| 47 | decidualization (GO:0046697) | 2.79886734 |
| 48 | protein localization to endosome (GO:0036010) | 2.78709041 |
| 49 | protein maturation by protein folding (GO:0022417) | 2.78211785 |
| 50 | hyaluronan catabolic process (GO:0030214) | 2.77392011 |
| 51 | response to copper ion (GO:0046688) | 2.74857263 |
| 52 | nucleoside salvage (GO:0043174) | 2.72238722 |
| 53 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.69795027 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 2.68981560 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.64707981 |
| 56 | vagina development (GO:0060068) | 2.64700880 |
| 57 | cellular response to vitamin D (GO:0071305) | 2.60857374 |
| 58 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59819799 |
| 59 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.59471718 |
| 60 | chondrocyte proliferation (GO:0035988) | 2.57830466 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.57714836 |
| 62 | negative regulation of ligase activity (GO:0051352) | 2.57058597 |
| 63 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.57058597 |
| 64 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.55702417 |
| 65 | natural killer cell mediated immunity (GO:0002228) | 2.54740048 |
| 66 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.54740048 |
| 67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.51868413 |
| 68 | positive regulation of vesicle fusion (GO:0031340) | 2.51371938 |
| 69 | regulation of macrophage chemotaxis (GO:0010758) | 2.45236169 |
| 70 | mesodermal cell differentiation (GO:0048333) | 2.45222697 |
| 71 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.44085487 |
| 72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.42883853 |
| 73 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40728424 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40728424 |
| 75 | substrate-dependent cell migration (GO:0006929) | 2.40693189 |
| 76 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.40587416 |
| 77 | response to redox state (GO:0051775) | 2.40511188 |
| 78 | regulation of vitamin metabolic process (GO:0030656) | 2.39670613 |
| 79 | response to magnesium ion (GO:0032026) | 2.39500521 |
| 80 | GDP-mannose metabolic process (GO:0019673) | 2.39271703 |
| 81 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.38981800 |
| 82 | response to increased oxygen levels (GO:0036296) | 2.38744372 |
| 83 | response to hyperoxia (GO:0055093) | 2.38744372 |
| 84 | regulation of chemokine biosynthetic process (GO:0045073) | 2.38244180 |
| 85 | response to peptidoglycan (GO:0032494) | 2.36606140 |
| 86 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.36310429 |
| 87 | hemidesmosome assembly (GO:0031581) | 2.35162493 |
| 88 | cellular response to vitamin (GO:0071295) | 2.34585528 |
| 89 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.34294723 |
| 90 | negative regulation of hemostasis (GO:1900047) | 2.31949770 |
| 91 | negative regulation of blood coagulation (GO:0030195) | 2.31949770 |
| 92 | positive regulation of cell junction assembly (GO:1901890) | 2.31436506 |
| 93 | positive regulation of focal adhesion assembly (GO:0051894) | 2.31436506 |
| 94 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.31354964 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.29152118 |
| 96 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.28315758 |
| 97 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.26314249 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 2.25600686 |
| 99 | Golgi transport vesicle coating (GO:0048200) | 2.25600686 |
| 100 | * cellular response to zinc ion (GO:0071294) | 13.6147492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.35134080 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.97340852 |
| 3 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.89037769 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.43986668 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.09035430 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.98351629 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.93618914 |
| 8 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.86750300 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72753789 |
| 10 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.72117476 |
| 11 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.44623597 |
| 12 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.44623597 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.37984142 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.37857452 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35590860 |
| 16 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.33771292 |
| 17 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.32707049 |
| 18 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.26814516 |
| 19 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.21685443 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10931925 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 2.08428095 |
| 22 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 2.08082859 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.07140771 |
| 24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.02817558 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01700333 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.01149210 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95138747 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.94854854 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93173505 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79832528 |
| 31 | ATF3_27146783_Chip-Seq_COLON_Human | 1.74030775 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72974259 |
| 33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.67026615 |
| 34 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63681544 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61853206 |
| 36 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.58056868 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56143042 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55924860 |
| 39 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.54847772 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52531460 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51779054 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50572515 |
| 43 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42707283 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.42441710 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42214477 |
| 46 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.39643830 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38335619 |
| 48 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.38219263 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35233214 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33266604 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33220069 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32006604 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28781609 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28513731 |
| 55 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.28221337 |
| 56 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26645703 |
| 57 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.24873442 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23226573 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22227064 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21238158 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21217350 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20549271 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17953425 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17110697 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16924059 |
| 66 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.16640583 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14831998 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14666100 |
| 69 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14085212 |
| 70 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11421528 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11059865 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09905821 |
| 73 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.08165512 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07175531 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06427571 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06361645 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05492350 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03225751 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03130383 |
| 80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.98997550 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97468075 |
| 82 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96965339 |
| 83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96327171 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94745055 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94343751 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.93922166 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92485400 |
| 88 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92422150 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92392064 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89682377 |
| 91 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.89589232 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89185135 |
| 93 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.88462493 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88075428 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87498990 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86969941 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86879574 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86879574 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86760940 |
| 100 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86304748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 5.61907333 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.26030150 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.97459284 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.23334691 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.09513593 |
| 6 | MP0010368_abnormal_lymphatic_system | 2.88263114 |
| 7 | MP0003279_aneurysm | 2.85531427 |
| 8 | MP0009840_abnormal_foam_cell | 2.80548239 |
| 9 | MP0005360_urolithiasis | 2.67502659 |
| 10 | MP0006054_spinal_hemorrhage | 2.58036095 |
| 11 | MP0004272_abnormal_basement_membrane | 2.50453508 |
| 12 | MP0005023_abnormal_wound_healing | 2.47034578 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.44563694 |
| 14 | MP0000343_altered_response_to | 2.30864595 |
| 15 | MP0001853_heart_inflammation | 2.24638598 |
| 16 | MP0000858_altered_metastatic_potential | 2.17183802 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.11390303 |
| 18 | MP0005623_abnormal_meninges_morphology | 1.95813655 |
| 19 | MP0003186_abnormal_redox_activity | 1.88844045 |
| 20 | MP0005164_abnormal_response_to | 1.86861589 |
| 21 | MP0005595_abnormal_vascular_smooth | 1.75060214 |
| 22 | MP0009785_altered_susceptibility_to | 1.74898518 |
| 23 | MP0002295_abnormal_pulmonary_circulatio | 1.69985653 |
| 24 | MP0001958_emphysema | 1.69936946 |
| 25 | MP0003448_altered_tumor_morphology | 1.69153855 |
| 26 | MP0003091_abnormal_cell_migration | 1.67280170 |
| 27 | MP0003828_pulmonary_edema | 1.66272074 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.64329685 |
| 29 | MP0004883_abnormal_blood_vessel | 1.53802937 |
| 30 | MP0000749_muscle_degeneration | 1.51052952 |
| 31 | MP0001542_abnormal_bone_strength | 1.48935841 |
| 32 | MP0004233_abnormal_muscle_weight | 1.48376992 |
| 33 | MP0009697_abnormal_copulation | 1.47083882 |
| 34 | MP0009053_abnormal_anal_canal | 1.47028501 |
| 35 | MP0001879_abnormal_lymphatic_vessel | 1.46812234 |
| 36 | MP0005275_abnormal_skin_tensile | 1.41591971 |
| 37 | MP0004510_myositis | 1.40881196 |
| 38 | MP0008260_abnormal_autophagy | 1.40267566 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.38381192 |
| 40 | MP0003075_altered_response_to | 1.35959118 |
| 41 | MP0006082_CNS_inflammation | 1.35415320 |
| 42 | MP0001849_ear_inflammation | 1.27423207 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.23726390 |
| 44 | MP0002933_joint_inflammation | 1.22930732 |
| 45 | MP0000733_abnormal_muscle_development | 1.22689169 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.22140609 |
| 47 | MP0005165_increased_susceptibility_to | 1.21361775 |
| 48 | MP0002060_abnormal_skin_morphology | 1.18694068 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.17101863 |
| 50 | MP0009764_decreased_sensitivity_to | 1.15487592 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.13939392 |
| 52 | MP0003436_decreased_susceptibility_to | 1.13890493 |
| 53 | MP0000762_abnormal_tongue_morphology | 1.08671658 |
| 54 | MP0005451_abnormal_body_composition | 1.04668429 |
| 55 | MP0003941_abnormal_skin_development | 1.02779372 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.01654707 |
| 57 | MP0005166_decreased_susceptibility_to | 0.99297866 |
| 58 | MP0002332_abnormal_exercise_endurance | 0.97515971 |
| 59 | MP0005464_abnormal_platelet_physiology | 0.96864878 |
| 60 | MP0002896_abnormal_bone_mineralization | 0.94835886 |
| 61 | MP0005503_abnormal_tendon_morphology | 0.91126060 |
| 62 | MP0000358_abnormal_cell_content/ | 0.90053788 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 0.87013332 |
| 64 | MP0001299_abnormal_eye_distance/ | 0.86766028 |
| 65 | MP0000249_abnormal_blood_vessel | 0.86604849 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.86487038 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.85825736 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.85116312 |
| 69 | MP0000759_abnormal_skeletal_muscle | 0.84602143 |
| 70 | MP0001243_abnormal_dermal_layer | 0.84254715 |
| 71 | MP0002837_dystrophic_cardiac_calcinosis | 0.83930432 |
| 72 | MP0003195_calcinosis | 0.82531872 |
| 73 | MP0008007_abnormal_cellular_replicative | 0.81473211 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.79627500 |
| 75 | MP0000747_muscle_weakness | 0.79154360 |
| 76 | MP0005390_skeleton_phenotype | 0.78062999 |
| 77 | MP0002972_abnormal_cardiac_muscle | 0.77471394 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.76240898 |
| 79 | MP0005330_cardiomyopathy | 0.76146801 |
| 80 | MP0009763_increased_sensitivity_to | 0.75386532 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.73690307 |
| 82 | MP0000751_myopathy | 0.71947102 |
| 83 | MP0002419_abnormal_innate_immunity | 0.71915722 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.71075977 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.71075977 |
| 86 | MP0001915_intracranial_hemorrhage | 0.71064070 |
| 87 | MP0004947_skin_inflammation | 0.70662667 |
| 88 | MP0010030_abnormal_orbit_morphology | 0.70325061 |
| 89 | MP0008469_abnormal_protein_level | 0.69544854 |
| 90 | MP0003795_abnormal_bone_structure | 0.66958608 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.66688476 |
| 92 | MP0000685_abnormal_immune_system | 0.64892822 |
| 93 | MP0005508_abnormal_skeleton_morphology | 0.62491579 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.61543997 |
| 95 | MP0005197_abnormal_uvea_morphology | 0.61371060 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59908354 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.59297688 |
| 98 | MP0008004_abnormal_stomach_pH | 0.58599757 |
| 99 | MP0005193_abnormal_anterior_eye | 0.58228016 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.57773762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vascular tortuosity (HP:0004948) | 4.62272674 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.61058438 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.93900073 |
| 4 | Aortic aneurysm (HP:0004942) | 3.71499273 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.63766464 |
| 6 | Abnormality of placental membranes (HP:0011409) | 3.51128323 |
| 7 | Amniotic constriction ring (HP:0009775) | 3.51128323 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.50557437 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45983598 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45983598 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45983598 |
| 12 | Arterial tortuosity (HP:0005116) | 3.24042773 |
| 13 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.17511715 |
| 14 | Aortic dissection (HP:0002647) | 3.15676928 |
| 15 | Atrophic scars (HP:0001075) | 2.97852832 |
| 16 | Follicular hyperkeratosis (HP:0007502) | 2.96255131 |
| 17 | Axonal loss (HP:0003447) | 2.92837567 |
| 18 | Ankle contracture (HP:0006466) | 2.88738351 |
| 19 | Spondylolisthesis (HP:0003302) | 2.77309681 |
| 20 | Generalized amyotrophy (HP:0003700) | 2.72651328 |
| 21 | Wormian bones (HP:0002645) | 2.67732964 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 2.65744861 |
| 23 | Cervical subluxation (HP:0003308) | 2.59140313 |
| 24 | Spinal rigidity (HP:0003306) | 2.56038314 |
| 25 | Hypokinesia (HP:0002375) | 2.47416908 |
| 26 | Mitral stenosis (HP:0001718) | 2.47021679 |
| 27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.43182938 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.43182938 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38159812 |
| 30 | Cardiovascular calcification (HP:0011915) | 2.38014515 |
| 31 | Bladder diverticulum (HP:0000015) | 2.36222504 |
| 32 | Esophageal neoplasm (HP:0100751) | 2.32896146 |
| 33 | Neoplasm of head and neck (HP:0012288) | 2.32896146 |
| 34 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.32534627 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.23536181 |
| 36 | Upper limb amyotrophy (HP:0009129) | 2.23536181 |
| 37 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.21101910 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 2.18556402 |
| 39 | Elbow flexion contracture (HP:0002987) | 2.18350279 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.17998727 |
| 41 | Fragile skin (HP:0001030) | 2.17499705 |
| 42 | Soft skin (HP:0000977) | 2.17377129 |
| 43 | Myocardial infarction (HP:0001658) | 2.16787577 |
| 44 | Petechiae (HP:0000967) | 2.16511579 |
| 45 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.11876081 |
| 46 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.11876081 |
| 47 | Delayed gross motor development (HP:0002194) | 2.11728539 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.10170524 |
| 49 | Vascular calcification (HP:0004934) | 2.10000738 |
| 50 | Popliteal pterygium (HP:0009756) | 2.09094730 |
| 51 | Rough bone trabeculation (HP:0100670) | 2.08438423 |
| 52 | Dilatation of the ascending aorta (HP:0005111) | 2.08122413 |
| 53 | Blue sclerae (HP:0000592) | 2.07996913 |
| 54 | Abnormality of dentin (HP:0010299) | 2.07313192 |
| 55 | Tetraparesis (HP:0002273) | 2.06659366 |
| 56 | Nemaline bodies (HP:0003798) | 2.04904765 |
| 57 | Aortic valve stenosis (HP:0001650) | 2.04443219 |
| 58 | Trismus (HP:0000211) | 2.03063092 |
| 59 | Glucose intolerance (HP:0000833) | 2.02816631 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.02416454 |
| 61 | Abnormal platelet function (HP:0011869) | 2.01345795 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.01345795 |
| 63 | Mitral regurgitation (HP:0001653) | 2.01180890 |
| 64 | Neck muscle weakness (HP:0000467) | 2.00981108 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.98176137 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 1.96763260 |
| 67 | Menorrhagia (HP:0000132) | 1.95607826 |
| 68 | Malnutrition (HP:0004395) | 1.95219681 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92949158 |
| 70 | Conjunctival telangiectasia (HP:0000524) | 1.91383664 |
| 71 | Weak cry (HP:0001612) | 1.91148320 |
| 72 | Bone cyst (HP:0012062) | 1.90898591 |
| 73 | Cerebral hemorrhage (HP:0001342) | 1.88580981 |
| 74 | Aortic regurgitation (HP:0001659) | 1.88444761 |
| 75 | Orthostatic hypotension (HP:0001278) | 1.88294530 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 1.87891717 |
| 77 | Slender build (HP:0001533) | 1.87192665 |
| 78 | Aplastic anemia (HP:0001915) | 1.86940894 |
| 79 | Nuclear cataract (HP:0100018) | 1.85653203 |
| 80 | Abnormality of the umbilical cord (HP:0010881) | 1.85286405 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 1.83271565 |
| 82 | Muscle fiber splitting (HP:0003555) | 1.81882801 |
| 83 | Mucosal telangiectasiae (HP:0100579) | 1.81866503 |
| 84 | Hypertensive crisis (HP:0100735) | 1.81847998 |
| 85 | Pterygium (HP:0001059) | 1.81662786 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81164124 |
| 87 | Wrist flexion contracture (HP:0001239) | 1.80498014 |
| 88 | Aplasia of the musculature (HP:0100854) | 1.78758931 |
| 89 | Bulbar palsy (HP:0001283) | 1.78527623 |
| 90 | Fatigable weakness (HP:0003473) | 1.76909267 |
| 91 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76909267 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.74719918 |
| 93 | Ovoid vertebral bodies (HP:0003300) | 1.74492932 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 1.74439675 |
| 95 | Oral leukoplakia (HP:0002745) | 1.73550074 |
| 96 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.73200816 |
| 97 | Increased serum ferritin (HP:0003281) | 1.72701685 |
| 98 | Progressive neurologic deterioration (HP:0002344) | 1.72612292 |
| 99 | Knee flexion contracture (HP:0006380) | 1.72591608 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 1.71706855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 4.38619820 |
| 2 | MAP3K12 | 4.13991715 |
| 3 | NME2 | 3.23897121 |
| 4 | LIMK1 | 3.01111842 |
| 5 | PAK4 | 2.95242009 |
| 6 | MUSK | 2.86501061 |
| 7 | TESK1 | 2.82714912 |
| 8 | TGFBR2 | 2.73303167 |
| 9 | EPHB2 | 2.73291624 |
| 10 | IRAK3 | 2.71248691 |
| 11 | BUB1 | 2.34106001 |
| 12 | LATS2 | 2.30560252 |
| 13 | PTK2 | 2.29721832 |
| 14 | MAP3K3 | 2.26057222 |
| 15 | ARAF | 2.21627789 |
| 16 | EIF2AK1 | 2.18484087 |
| 17 | ILK | 2.03474033 |
| 18 | FLT3 | 1.96657038 |
| 19 | MOS | 1.96478250 |
| 20 | EPHA2 | 1.87417054 |
| 21 | MST1R | 1.86884839 |
| 22 | DDR2 | 1.85751930 |
| 23 | ERBB4 | 1.79771094 |
| 24 | ABL2 | 1.77830810 |
| 25 | MET | 1.68891413 |
| 26 | CDK8 | 1.68430404 |
| 27 | PBK | 1.65757120 |
| 28 | PDGFRA | 1.64697720 |
| 29 | EIF2AK3 | 1.55959389 |
| 30 | MST4 | 1.51860495 |
| 31 | NTRK1 | 1.43129502 |
| 32 | STK16 | 1.42318081 |
| 33 | GRK7 | 1.33098411 |
| 34 | NEK1 | 1.25385653 |
| 35 | PAK2 | 1.20910942 |
| 36 | LMTK2 | 1.06607263 |
| 37 | PIM2 | 1.06431099 |
| 38 | PTK2B | 1.06362856 |
| 39 | ROCK1 | 1.04900158 |
| 40 | TAOK2 | 0.99447130 |
| 41 | EPHB1 | 0.99292003 |
| 42 | DAPK3 | 0.98342979 |
| 43 | STK38 | 0.97672016 |
| 44 | PAK1 | 0.94551903 |
| 45 | VRK2 | 0.93919449 |
| 46 | PRKG2 | 0.93546779 |
| 47 | ZAP70 | 0.89624223 |
| 48 | PAK6 | 0.86532121 |
| 49 | TTN | 0.84241073 |
| 50 | ROCK2 | 0.82097940 |
| 51 | TESK2 | 0.81324217 |
| 52 | ERN1 | 0.81141336 |
| 53 | KDR | 0.76812878 |
| 54 | CDK9 | 0.74085285 |
| 55 | MAP3K9 | 0.69332971 |
| 56 | TBK1 | 0.69104991 |
| 57 | ADRBK1 | 0.66490006 |
| 58 | MAPKAPK3 | 0.66470070 |
| 59 | TGFBR1 | 0.66351081 |
| 60 | BMPR2 | 0.65687396 |
| 61 | BMX | 0.65283809 |
| 62 | CAMK2G | 0.64842982 |
| 63 | PIK3CG | 0.60799253 |
| 64 | PDGFRB | 0.58640236 |
| 65 | BCKDK | 0.54925153 |
| 66 | STK24 | 0.54641470 |
| 67 | STK10 | 0.53011677 |
| 68 | DAPK1 | 0.48771508 |
| 69 | MAP3K8 | 0.47380812 |
| 70 | MAP2K3 | 0.45335238 |
| 71 | DMPK | 0.44740131 |
| 72 | MAP3K13 | 0.43945498 |
| 73 | TRPM7 | 0.41947846 |
| 74 | CAMK2D | 0.41926266 |
| 75 | JAK3 | 0.39724195 |
| 76 | BRAF | 0.38389067 |
| 77 | BLK | 0.38134742 |
| 78 | CLK1 | 0.37347681 |
| 79 | NEK9 | 0.37285839 |
| 80 | TYK2 | 0.36459919 |
| 81 | GSK3A | 0.36353717 |
| 82 | STK4 | 0.36309585 |
| 83 | ABL1 | 0.36004171 |
| 84 | IKBKB | 0.35950273 |
| 85 | TRIB3 | 0.33450684 |
| 86 | PDK2 | 0.33395625 |
| 87 | CSK | 0.32550520 |
| 88 | CDC42BPA | 0.31416200 |
| 89 | MAPKAPK2 | 0.29993103 |
| 90 | PRKD2 | 0.29301278 |
| 91 | PRKCD | 0.28994407 |
| 92 | MAP2K1 | 0.28192891 |
| 93 | KSR2 | 0.27706004 |
| 94 | AURKA | 0.26070077 |
| 95 | MAP3K2 | 0.25915099 |
| 96 | KSR1 | 0.25497864 |
| 97 | RAF1 | 0.25180889 |
| 98 | INSR | 0.23255554 |
| 99 | STK38L | 0.22218463 |
| 100 | LATS1 | 0.21768842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.49262106 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.39785243 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.24647167 |
| 4 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.75089738 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.20142977 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.11859535 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.09857618 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.06945984 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.06242104 |
| 10 | Salmonella infection_Homo sapiens_hsa05132 | 2.04500996 |
| 11 | Shigellosis_Homo sapiens_hsa05131 | 1.97034980 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92729915 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.88798480 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.88045284 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87725933 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86756547 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.75285145 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.66488099 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.66260306 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56610808 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.56045182 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.53382390 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47778290 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.47624205 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47021611 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.44134540 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44116701 |
| 28 | Focal adhesion_Homo sapiens_hsa04510 | 1.40949549 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.40689902 |
| 30 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.40522980 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34760094 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33316775 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27459823 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24578655 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24500049 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.23760630 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.21703109 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.19513505 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13775661 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13602875 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.10976220 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10309253 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07892127 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04103030 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02630751 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02300741 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.01443548 |
| 48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98245224 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97748013 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97328920 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92101101 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92041819 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89179080 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88139781 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84482791 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83137553 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80305259 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79703629 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75788595 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73266715 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72841361 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72500564 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70815036 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.70493705 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70082546 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69024958 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68162543 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66623456 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65927331 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65736960 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64695452 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64265992 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61992706 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61450248 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57985773 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.56890057 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51241639 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49026341 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48594480 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47213390 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44404794 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44226180 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43643352 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42990596 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41495544 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.37127302 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37023364 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36278182 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34613319 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32585263 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31934458 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31839979 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29205840 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28960163 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.28645668 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27424316 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.25848470 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.24442589 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22682469 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22437771 |

